Salidroside

Category
adaptogen
Routes
Oral (PO)
Half-Life (t½)
PO: 1.2h
Formula
C14H20O7
Molecular Weight
300.3 g/mol
PubChem CID
159278
Aliases
Rhodioloside, 2-(4-Hydroxyphenyl)ethyl β-D-glucoside

Pharmacological Mechanism

Tyrosol glucoside — the principal active adaptogen of Rhodiola rosea. Crosses BBB (brain-to-plasma AUC ~0.2 in rats). Mechanisms: PI3K/AKT activation, AMPK induction, Nrf2-mediated antioxidant response, NF-κB inhibition, and modest monoamine-oxidase inhibition contributing to the fast-onset antifatigue / antidepressant signal. Rat PK: Cmax ~6–12 µg/mL after 25 mg/kg oral at Tmax 0.5 h, t½ 1.5–2.5 h, absolute bioavailability 51–98% depending on dose (Fan 2020 review). Hepatic UGT-mediated glucuronidation dominant elimination route. No definitive human PK published.

Half-Life & Elimination Curve (PO: 1.2h)

100%50%25%12.5%0%0h0×t½1.2h1×t½2.4h2×t½3.6h3×t½4.8h4×t½6h5×t½0×t½ (0h): 100% remaining1×t½ (1.2h): 50% remaining2×t½ (2.4h): 25% remaining3×t½ (3.6h): 12.5% remaining4×t½ (4.8h): 6.3% remaining5×t½ (6h): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½1.2h50%
  • 2×t½2.4h25%
  • 3×t½3.6h12.5%
  • 4×t½4.8h6.3%
  • 5×t½6h3.1%
Elimination t½1.2h (PO)
Rate Constant (ke)0.578 h⁻¹
97% Washout (5×t½)6h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References